Asaf Danziger Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 weeks, 4 days ago
Asaf Danziger has an estimated net worth of at least $28.6 million*, as of Oct. 28, 2026. They own 416,473 shares of NVCR stock. They have sold 212,500 shares of NVCR stock since 2021, for an estimated $22.6 million.
Asaf Danziger $NVCR SEC Form 4 Insider Trading
Asaf Danziger has filed a total of 13 insider trades in $NVCR since 2021. Their most recent trade was a sale of 8,369 shares, made on Jan 05, 2023. Their largest trade was a sale of 187,500 shares, made on Jan 05, 2023. We estimate that they now own 416,473 shares of $NVCR, worth an estimated $6.0 million.
Insider Trading at $NVCR
There have been a total of 203 insider trades reported at $NVCR since 2021, with 106,524 shares purchased and 766,868 shares sold. The most active insider traders in $NVCR stock have been Frank X Leonard, Frank X Leonard, and Ashley Cordova. The most recent trade was a sale of 3,079 shares reported by Mukund Paravasthu (Chief Operating Officer), made on Nov 09, 2026.
History of Insider Stock Trades by Asaf Danziger
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NVCR
|
Sale | 8,369 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 2,000 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 4,568 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 3,702 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 1,395 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 999 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 2,123 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 1,344 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 500 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Sale | 187,500 | Jan 05, 2023 | Jan. 9, 2023, 7:18 p.m. |
NVCR
|
Purchase | 3,870 | Nov 26, 2021 | Nov. 29, 2021, 5:48 p.m. |
NVCR
|
Purchase | 1,000 | Nov 26, 2021 | Nov. 29, 2021, 5:48 p.m. |
NVCR
|
Purchase | 104 | Nov 26, 2021 | Nov. 29, 2021, 5:48 p.m. |
$NVCR Executives and Stock Owners with Insider Trades
-
Frank X Leonard, Chief Development Officer
-
Frank X Leonard, President, CNS Cancers US
-
Ashley Cordova, Chief Financial Officer
-
Asaf Danziger, Chief Executive Officer
-
Wilhelmus Cm Groenhuysen, Chief Operating Officer
-
Pritesh Shah, Chief Commercial Officer
-
Mukund Paravasthu, Chief Operating Officer
-
William Patrick Burke, Chief Human Resources Officer
-
Frank X Leonard, EVP, Pres., Novocure Oncology
-
Ely Benaim, Chief Medical Officer
-
Pritesh Shah, Chief Growth Officer
-
Michal Nath Puri, Chief Human Resources Officer
-
Christoph Brackmann, Chief Financial Officer
-
Ashley Cordova, Chief Executive Officer
-
Uri Weinberg, Chief Science Officer
-
Todd Christopher Longsworth, General Counsel
-
Uri Weinberg, Chf Medical and Innovation Ofr
-
William F Doyle, Executive Chairman
-
Frank X Leonard, Chief Executive Officer
-
Uri Weinberg, Chief Innovation Officer
-
Nicolas Leupin, Chief Medical Officer
-
Nicolas Leupin, Former Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.